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Abstract
Major progress is being made in vaccines against Respiratory Syncytial Virus (RSV), with 
multiple vaccine candidates currently in the clinical phase of development. Making an investment 
case for public sector financing of RSV vaccine will require estimation of burden, cost-
effectiveness and impact. The aim of this study is to determine the proportion, age distribution and 
clinical spectrum of RSV associated hospitalizations in children in Karachi, Pakistan. A three 
years prospective study was conducted at the Aga Khan University hospital in Karachi, a city of 20 
million in south Pakistan, from August 2009 to June 2012. Children less than five years old 
admitted with acute respiratory infections (ARI) were enrolled. Throat swabs were collected and 
tested for RSV using real-time PCR. Multivariable log binomial regression analysis was 
performed to identify the associated factors of RSV infection. Out of 1150 children enrolled, RSV 
was detected among 223 (19%). Highest rate of RSV detection was in young infants less than 3 
months of age (48/168, 29%), which accounted for 22% of all RSV detected. Most common 
diagnosis in RSV positive infants (<12 months of age) was bronchiolitis followed by pneumonia, 
while in older children between the ages of one and five years of age, pneumonia and asthma were 
the most common diagnosis. Although identified year-round, RSV was most prevalent from 
August to October with peak in September, coinciding with the rainy season. This study identified 
RSV to be independently associated with younger age (p=0.036), rainy season (p<0.001), post-
tussive emesis (p=0.008), intubation (p=0.003) and discharge diagnosis of bronchiolitis (p=0.004). 
Vaccines against RSV that target this age group are likely to yield remarkable benefit.
Keywords
Respiratory syncytial virus; RSV; pneumonia; ARI; bronchiolitis; asthma; Karachi; Log binomial 
regression; Pakistan
INTRODUCTION
RSV is the most important viral cause of severe ARI in children worldwide [Nair et al., 
2010]. ARI account for approximately two million deaths per year in children globally, 70% 
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of which are concentrated in Africa and South Asia [Bryce et al., 2005; Williams et al., 
2002]. RSV associated deaths are estimated to be 66,000-199,000 in children under 5 years 
of age and 15-40% of pediatric hospitalizations with ARI in developing countries are 
attributable to RSV. This makes RSV one of the leading targets of public health 
interventions [Breiman et al., 2013; Hall et al., 2009; Nair et al., 2010].
The field of RSV vaccines is advancing at an unprecedented pace. While more than 50 RSV 
vaccine candidates are currently in development, around ten candidates are either entering, 
or are already in, clinical trials [Modjarrad et al., 2015]. Live attenuated approaches have 
been in development for decades and until recently were the only candidates in clinical 
testing. More recently there have been significant advances in RSV vaccine development 
using other technologies. While most of these are still at the preclinical stage, four of these 
newer candidates have now entered clinical development – Novavax (Ph2), GSK (Ph1), and 
MedImmune (Ph1) testing RSV F protein-based candidates and GSK (Ph1, 2013 acquisition 
of Okairos) testing an Adenovirus/MVA prime/boost candidate expressing RSV F, and a N 
and M2-1 fusion protein [PD-VAC, 2014]. The preliminary phase 2 results of RSV F 
nanoparticle vaccine made by Novavax show that immunizing mothers with this vaccine was 
safe for fetuses and could protect infants against RSV [NOVAVAX, 2015].
In order to make a case for vaccine introduction in resource-limited settings and guide the 
optimal vaccine delivery strategy, it is important to understand the morbidity and mortality 
risks of RSV associated hospitalizations in different age groups, particularly in settings with 
the highest burden of disease. With this goal in mind, we conducted a three year prospective 
surveillance study to determine the frequency, clinical features and severity of RSV in 
children of different age groups hospitalized with ARI in a tertiary care hospital of Karachi, 
Pakistan.
METHODS
The study was conducted from August 2009 to July 2012 at the Aga Khan University 
Hospital in Karachi, Pakistan. Pakistan, with the population of approximately 185 million 
[WorldBank, 2015], is one of the major countries in South Asia, which together with Africa 
account for 70% of the ARI associated mortality in children worldwide [Bryce et al., 2005]. 
Karachi is the major cosmopolitan city of Pakistan, located on the coast of Arabian Sea with 
a population of 20 million. Karachi has relatively mild climate with two main seasons of 
summer and winter, and receives the monsoon rains between July and September. Aga Khan 
University Hospital is a tertiary care, not-for profit, private sector hospital. It has general 
pediatric ward with 84 beds and a state of the art pediatric intensive care unit (ICU). It caters 
mainly to the population of Karachi but also receives referrals from the rest of the Sindh 
province. About three-quarters of the patients belong to lower and middle socioeconomic 
group. Financial assistance is available to those who cannot afford the services, and about 
25% of the inpatients receive such assistance.
The inclusion criteria for enrollment in this study included age less than 5 years and 
admission to the hospital within 48 hours prior to enrollment with one or more of the 
following admission diagnosis as listed by the treating medical team: ARI, apnea, asthma 
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exacerbation, bronchiolitis, croup, cystic fibrosis exacerbation, febrile neonate, febrile 
seizure, respiratory distress, otitis media, pharyngitis, pneumonia, sinusitis, and upper 
respiratory infection (URI). The admission diagnoses given by the primary team were taken 
as such, and were not verified or reclassified by the study physicians. Newborns who never 
left the hospital were excluded. The study was approved by the Ethical Review Committee 
of the Aga Khan University. After getting a written informed consent from parents/guardian, 
demographic and clinical information about the current illness was recorded. A throat swab 
was obtained using commercial flocked swabs (Diagnostics Hybrid Inc.) and was 
transported immediately to the research laboratory in the Universal Transport Media 
(Diagnostics Hybrid Inc.) for testing of RSV, HMPV and Influenza using monoplex real-
time RT-PCR assay. RNA was extracted using QiaAmp Viral RNA mini Kit (Qiagen) 
according to the manufacturer's instructions. The primers and probes for RSV were 
according to the CDC protocol of real-time RT-PCR for RSV [Mentel et al., 2003]. After 
discharge from the hospital, the medical records of all enrolled participants were reviewed 
and data about the inpatient workup, management and clinical course were recorded.
STATISTICAL ANALYSIS
Descriptive analysis was performed to describe age of children and proportion of respiratory 
virus etiology. Associations between socio-demographic characteristics, seasonality, clinical 
manifestations, and RSV infection were assessed using univariable and multivariable log 
binomial regression analysis. All the variables found significant at p <0.30 at the univariate 
level were tested simultaneously in the multivariable regression model. The final model with 
variables significant at 5% level of significance was selected using the best subset method. 
Crude and adjusted risk ratios with 95% confidence intervals were calculated. Statistical 
analysis was performed using Stata software (Version 11).
RESULTS
A total of 3830 children less than 5 years old were admitted at AKUH with ARI and 
associated diagnosis during the study period. Out of these, 30% had pneumonia, 25% had 
asthma, 24% had a URI and 22% had bronchiolitis. Acute URI admissions peaked in 
February and were relatively lower in the months of June and July (Figure 1). This was more 
apparent in the years 2010 and 2012. Cases of asthma did not show any specific trend. 
Patients with bronchiolitis did not have a particular peak, but fewer cases were observed 
from April to July each year. Pneumonia, on the other hand, showed a pattern of two peaks a 
year- in February and in the months of August to September.
A total of 1150 (33%) out of 3830 children were enrolled in the study. The proportion of 
RSV cases in various months varied from 2% to 43%. The cases started increasing in the 
month of July (14%) reaching the peak (43%) in September and then slowly declining 
reaching to 8% in the month of December. The rate of RSV positivity is lowest during Jan –
Feb and highest during September-October (Figure 2). Figure 3 shows the percentage 
distribution of RSV associated ARI cases with various discharge diagnoses across different 
months of enrollments. Cases of Pneumonia showed higher RSV positivity between the 
months of April and June While on the other hand cases of bronchiolitis and upper 
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respiratory infections during the month of August to October showed the similar trend of 
higher cases attributed to RSV.
The most common admission diagnosis among those enrolled was pneumonia (38%) 
followed by bronchiolitis (28%), asthma (17%) and URI (13%). RSV was detected in 
223(19%) of the enrolled children (Table 1). Overall, 65% of the enrolled children were 
male with a slightly higher proportion among RSV negative children (66%) than RSV 
positive (62%). Children with RSV were relatively younger (median age 7; IQR 3-13 
months) than RSV negative children (median 10; IQR 4.9-21 months). About 30% of the 
enrolled children had a smoker within the household with almost similar proportion between 
those with RSV positive and negative status. More than 85% of the enrolled children were 
presented with cough, followed by fever (73%), nasal congestion (69%), and shortness of 
breath (68%). About 2% of the children required intubation with slightly higher proportion 
among RSV positive cases than RSV negative (3.6% vs. 2% respectively). In addition, 
41(3.6%) children needed admission/transferred to the intensive care unit (ICU) and 22 
children (1.9%) died during hospitalization (2 among RSV positive and 20 among RSV 
negative).
The age-wise distribution of RSV and its detection rate is summarized in Table 2. Of the 223 
children testing positive for RSV, 148 were less than 12 months old (22% detection rate for 
RSV), 47 were between 12 and 24 months (18% detection rate) and 27 were between 24 and 
60 months old (12% detection rate). During the first year, the highest detection rate was in 
young infants less than 3 months old (29%), followed by infants between 3 and 6 months of 
age (23%). Cough and nasal congestion were the predominant clinical features while fever 
was reported by parents in two third of the RSV positive cases across all age groups. 
Bronchiolitis was the leading discharge diagnosis in RSV positive children less than 12 
months old, followed by pneumonia. Pneumonia was the most common diagnosis in RSV 
positive children between the ages of 1 and 5 years, followed by asthma exacerbation.
The multivariable regression analysis showed that the risk of RSV linearly decreases with 
increasing age (adjusted RR 1.81; 95% CI 1.17-2.81 among <3 months old children, RR 
1.51; 95%CI 0.99-2.32 among 3-5 months and RR 1.15; 95%CI 0.77-1.72 among 6-12 
months considering ≥12 months old children as the reference category). Also, the risk of 
RSV is highest during July-Sep (Adjusted RR 3.56; 95%CI 2.33-5.43), followed by Oct-Dec 
(Adjusted RR 2.89; 95%CI 1.88-4.44) as compared to the first quarter of the year. We also 
found that RSV positive children were almost four times more likely to be intubated as 
compared to RSV negative children (Adjusted RR 3.97; 95% CI 1.59-9.91). Post tussive 
emesis, and diagnosis of bronchiolitis were also significantly associated with the RSV 
infection (Adjusted RR 1.54; 95%CI 1.12-2.11 and RR 1.63;95%CI 1.16-2.27 respectively). 
(Table 3)
DISCUSSION
Our study showed that RSV circulates throughout the year in Karachi, Pakistan, but the peak 
season is during the monsoon rains between July and September each year. These findings 
are consistent with studies conducted in coastal areas of India, Thailand as well as Malaysia 
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where monsoon season follows a similar pattern [John et al., 1991; Khor et al., 2012; Naorat 
et al., 2013]. Our findings are also consistent with a previous study conducted in a large 
public sector tertiary care hospital of Karachi, Pakistan [Ali et al., 2013]. On the other hand, 
a study from Islamabad and Rawalpindi, Pakistan, showed that RSV was frequently detected 
from December through February [Tariq et al., 2005]. This is likely due to climatic 
differences between different cities, with Islamabad and Rawalpindi having temperate 
climate while Karachi having milder, coastal climate. In areas with temperate and 
Mediterranean climates, RSV outbreaks occur during winter months while in tropical 
settings, RSV infections typically peak after seasonal rainfalls [Weber et al., 1998].
RSV accounted for almost a third of the ARI associated hospitalizations in young infants 
less than 3 months old in our study. Risk of RSV among children less than three months of 
age hospitalized with ARI was almost 80% higher compared to those above one year of age. 
These findings are consistent with a study conducted in the USA by Hall et al, showing the 
highest risk of RSV among children less than five months of age [Hall et al., 2009]. The 
higher burden of disease in young infants has implications for the anticipated vaccine 
program. A future RSV vaccine which aims to protect infants in this age group, either 
through maternal immunization or immunization to the baby immediately after birth will 
likely have most public health impact.
We found that children with RSV infection were more likely to have post-tussive emesis and 
be diagnosed as bronchiolitis compared to children admitted for ARI but testing negative for 
RSV. Interestingly, children with RSV associated ARI were almost 4 times more likely to be 
intubated compared to children who had a non-RSV associated ARI. This increased severity 
of disease associated with RSV has been infrequently reported in the literature [Weber et al., 
1998]. Two children enrolled in our study who had RSV associated ARI died, but the overall 
mortality rate was not different in RSV positive and RSV negative children. Of the two 
children who had RSV and died during hospitalization, one was 3.5 years old boy with 
Downs's syndrome, ventricular septum defect and pulmonary hypertension, who died after 7 
days of hospitalization in the ICU. Besides RSV, he was also found to have influenza and 
pseudomonas bacteremia. The second child was a 2 years 4 months old girl, born after 31 
weeks gestation but otherwise previously healthy, who was hospitalized with pneumonia for 
3 days, which included 1 day in the ICU requiring mechanical ventilation before her death.
Strengths of this study include PCR based testing for RSV, which is the gold standard and 
often not available outside research settings in the third world settings. Data was collected 
prospectively over three years, so seasonal inferences are likely valid. The study also had 
multiple limitations. Although our study has a relatively large sample size of 1150 infants, a 
significant proportion of the possibly eligible children were not enrolled. Major reasons for 
non-enrollment included unclear diagnosis at the time of admission, lack of surveillance 
during weekends, early discharge before the family could be approached for enrollment, 
delay of greater than 48 hours in approaching family for enrollment (particularly when the 
patients were admitted over the weekend), and unavailability or refusal of parents to give 
consent. Nonetheless, as the figures 1-3 show, the enrollment pattern followed the pattern of 
ARI admissions, so the seasonality and the relative distribution of different syndromes is 
likely valid. Study was performed at a single tertiary care hospital which may not represent 
Ali et al. Page 5
J Med Virol. Author manuscript; available in PMC 2018 July 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
the entire socioeconomic spectrum of Pakistani population and likely does not represent 
patterns from other cities located in different lattitudes. With majority of pediatric deaths 
occurring at home because of low rates of care seeking at tertiary care by the population, the 
etiological spectrum in the community based studies may be different than what has been 
identified in this hospital based study. For more accurate estimation of RSV burden in the 
country, community based studies should ideally be conducted.
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Figure 1. 
Monthly number of cases for each diagnosis among the total admissions at Aga Khan 
University Karachi
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Figure 2. 
Percentage of RSV infection among children less than 5 years of age across months of 
enrollment during Aug 2009 to July 2012 (Bar chart)
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Figure 3. 
Percentage distribution of ARI attributed to RSV infection among children less than 5 years 
of age across the months of enrollment during Aug 2009 to July 2012. (Bar chart)
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Table 1
Comparison of enrolled RSV-positive and negative children less than 5 years old, admitted with acute 
respiratory illness at Aga Khan University Hospital Karachi, Pakistan (Aug 2009-Jul 2012)
Baseline characteristics RSV positive n=223 (%) RSV negative n=927 (%) Total N (%)
Age in months (median, IQR) 7 (3 - 13.4) 10 (4.9 - 21) 9(4.1-18.8)
Age groups (months):
0-2 48 (21.5) 120 (12.9) 168 (14.6)
3-5 47 (21.1) 157 (16.9) 204 (17.7)
6-11 53 (23.8) 242 (26.1) 295 (25.7)
12-60 75 (33.6) 408 (44.0) 483 (42.0)
Male 139 (62.3) 611 (65.9) 750 (65.2)
Birth weight (kg) (median, IQR) 2.8 (2.5 - 3.2) 2.9 (2.5 - 3.3) 2.9 (2.5-3.3)
Months of breast feeding (median, IQR) 6 (3 - 12) 6 (2 - 12) 6 (2-12)
Day care attendance 11 (5.0) 50 (5.5) 61 (5.4)
Smokers in the house 62 (28.1) 281 (30.7) 343 (30.2)
Number of household members (median, IQR) 7 (5 - 10) 7 (5 - 10) 7 (5-10)
Clinical features
fever 152 (68.2) 688 (74.2) 840 (73.0)
Cough 200 (89.7) 805 (86.8) 1005 (87.4)
wheezing/noisy breathing 120 (53.8) 454 (49.0) 574 (49.9)
poor appetite 137 (61.4) 559 (60.3) 696 (60.5)
shortness of breath 164 (73.5) 619 (66.8) 783 (68.1)
ear ache 23 (10.3) 119 (12.8) 142 (12.3)
sore throat 110 (49.3) 456 (49.2) 566 (49.2)
Post-tussive emesis 89 (39.9) 294 (31.7) 383 (33.3)
nasal congestion 168 (75.3) 620 (66.9) 788 (68.5)
Hospital course
Intubated 8 (3.6) 19 (2.0) 27 (2.3)
ICU admission or transfer 9 (4.0) 32 (3.5) 41 (3.6)
Died during hospitalization 2 (0.9) 20 (2.2) 22 (1.9)
Units are number (%) unless indicated otherwise in the left column.
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Table 2
Age-wise distribution of RSV associated ARI admissions at the Aga Khan University Hospital (Aug 2009-Jul 
2012)
0-2 months n=168(%) 3-5 months n=204(%) 6-11 months n=295(%) 12-60 months n=483(%)
% RSV positive 48 (28.6) 47 (23.0) 53 (18.0) 75 (15.5)
Clinical features of RSV 
positive patients
Fever 26 (54.2) 29 (61.7) 39 (73.6) 58 (77.3)
Cough 44 (91.7) 43 (91.5) 46 (86.8) 67 (89.3)
Wheezing/Noisy breathing 28 (58.3) 23 (48.9) 31 (58.5) 38 (50.7)
Poor appetite 31 (64.6) 30 (63.8) 42 (79.2) 34 (45.3)
Shortness of breath 35 (72.9) 37 (78.7) 40 (75.5) 52 (69.3)
Ear ache 3 (6.3) 8 (17.0) 7 (13.2) 5 (6.7)
Sore throat 22 (45.8) 23 (48.9) 32 (60.4) 33 (44.0)
Post-tussive emesis 17 (35.4) 17 (36.2) 20 (37.7) 35 (46.7)
Nasal congestion 40 (83.3) 32 (68.1) 42 (79.2) 54 (72.0)
Discharge diagnosis of RSV 
positive patients*
Pneumonia 17 (35.4) 17 (36.2) 20 (37.7) 33 (44.0)
Bronchiolitis 26 (54.2) 25 (53.2) 23 (43.4) 15 (20.5)
Asthma 4 (8.3) 4 (8.5) 7 (13.2) 16 (21.3)
Upper respiratory infection 3 (6.3) 0 8 (15.1) 9 (12.0)
Others 4 (8.3) 6 (12.8) 3 (5.7) 7 (9.3)
Hospital course of RSV 
positive patients
Length of stay(days), mean (SD) 2.7 (2.6) 3.2 (2.6) 3.6 (2.8) 3.5 (4.4)
Intubated 2 (4.2) 1 (2.1) 1 (1.9) 4 (5.3)
ICU admission or transfer 2 (4.2) 1 (2.1) 2 (3.8) 4 (5.3)
Death during hospitalization 0 0 0 2 (2.7)
Units are number (%) unless indicated otherwise in the left column
*
Multiple diagnoses possible,
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Table 3
Correlates of RSV infection among children less than five years of age admitted with acute respiratory illness 
at Aga Khan University Hospital Karachi, Pakistan (Aug 2009-Jul 2012)
Baseline characteristics Crude RR (95% CI) P value for Crude 
RR
Adj RR (95% CI) P value for Adj 
RR
Age in months 0.97 (0.96-0.99) <0.001 - -
Age groups (months)
0-2 1.84 (1.28-2.64) 1.81 (1.17-2.81)
3-5 1.48 (1.03-2.14) 0.006 1.51 (0.99-2.32) 0.036
6-11 1.16 (0.81-1.65) 1.15 (0.77-1.72)
12-60 1 1
Male 0.88 (0.67-1.16) 0.366 - -
Birth weight (kg) 0.89 (0.73-1.09) 0.264 - -
Born early 0.99 (0.72-1.35) 0.952 - -
Enrollment period (Seasonality):
Jan-March 1 1
April-June 1.04 (0.59-1.82) <0.001 1.03 (0.56-1.89) <0.001
July-Sep 2.77 (1.90-4.03) 3.56 (2.33-5.43)
Oct-Dec 2.29 (1.56-3.38) 2.89 (1.88-4.44)
Duration of breast feeding (months) 0.99 (0.96-1.02) 0.566 - -
Day care attendance 1.09 (0.59-2.00) 0.777 - -
Smokers in the house 1.10 (0.83-1.49) 0.489 - -
Number of household members 1.01 (0.98-1.03) 0.647 - -
Crowding index (household members/# bedrooms) 0.94 (0.84-1.06) 0.312 - -
Clinical features
fever 0.79 (0.60-1.05) 0.101 - -
Cough 1.26 (0.81-1.93) 0.303 - -
wheezing/noisy breathing 1.02 (0.99-1.05) 0.245 - -
poor appetite 0.98 (0.86-1.12) 0.780 - -
shortness of breath 1.14 (0.98-1.33) 0.081 - -
ear ache 0.93 (0.81-1.08) 0.357 - -
sore throat 1.01 (0.94-1.07) 0.974 - -
Post-tussive emesis 1.05 (1.01-1.09) 0.037 1.54 (1.12-2.11) 0.008
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Baseline characteristics Crude RR (95% CI) P value for Crude 
RR
Adj RR (95% CI) P value for Adj 
RR
nasal congestion 1.05 (1.01-1.10) 0.029 - -
Hospital course
Intubated 1.55 (0.76-3.13) 0.225 3.97 (1.59-9.91) 0.003
ICU admission or transfer 1.14 (0.58-2.22) 0.705 - -
Length of hospital stay (days) 1.01 (0.97-1.04) 0.667 - -
Died during hospitalization 0.46 (0.12-1.87) 0.280 - -
Discharge diagnosis
URI 0.67 (0.42-1.06) 0.09 - -
Asthma 0.78 (0.53-1.14) 0.20 - -
Pneumonia 1.06 (0.81-1.38) 0.69 - -
Bronchiolitis 1.70 (1.30-2.22) <0.001 1.63 (1.16-2.27) 0.004
Risk ratio based on log binomial regression analysis. Outcome variable: RT-PCR status for RSV=1 for positive and 0 for negative. Variables with p 
values less than 0.30 at the univariate level were taken forward to the multivariables regression model.
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